SEBI Issues Administrative Warning to Dabur India Over Disclosure Lapses
Dabur India Ltd 路 Others (Uncategorized) 路 06 Nov 2026, 9:58 pm
SEBI Issues Administrative Warning to Dabur India Over Disclosure Lapses SEBI issued an administrative warning letter to Dabur India on 6th Nov'26 regarding violations under Regulation 30 of SEBI LODR Regulations. The regulatory action stems from Dabur's delay in disclosing a warning letter received from the US FDA on 24th Jul'26. The regulator warned the company to prevent future lapses, requiring the communication to be tabled before the Board of Directors. Dabur confirmed that the warning letter has no financial or operational impact on the company's activities and stated it will take necessary corrective steps.
Original exchange filing (PDF)
More announcements from Dabur India Ltd
- Re-affirmation of Credit Rating by CRISIL Ratings Limited 路 17 Nov 2026
- Change in Senior Management Personnel of the Company 路 14 Nov 2026
- Closure of Dabur International Limited, United Kingdom Branch, a branch of the wholly owned subsidiary of the Company. 路 14 Nov 2026
- Submission of information under Regulation 30(5) of the SEBI (LODR) Regulations, 2015 路 13 Nov 2026
- Dissolution of Dabur Pars LLC a subsidiary of Dabur International Limited, a wholly owned subsidiary of the Company. 路 11 Nov 2026
- Closure of Atlanta Body and Health Products (Pty) Ltd., a wholly owned subsidiary of Dermoviva Skin Essentials Inc. a step down subsidiary of the Company. 路 10 Nov 2026
- Transcript of Analyst/ Institutional Investor Meet held on November 05, 2026 路 10 Nov 2026
- Allotment of Equity Shares under Dabur Employees Stock Option Scheme 2000 路 06 Nov 2026
